Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iBio (IBIO) Return on Equity (2016 - 2025)

Historic Return on Equity for iBio (IBIO) over the last 17 years, with Q4 2025 value amounting to 0.44%.

  • iBio's Return on Equity rose 4100.0% to 0.44% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.44%, marking a year-over-year increase of 4100.0%. This contributed to the annual value of 1.02% for FY2025, which is 5000.0% down from last year.
  • Per iBio's latest filing, its Return on Equity stood at 0.44% for Q4 2025, which was up 4100.0% from 0.57% recorded in Q3 2025.
  • iBio's 5-year Return on Equity high stood at 0.25% for Q1 2021, and its period low was 2.28% during Q1 2023.
  • Over the past 5 years, iBio's median Return on Equity value was 0.53% (recorded in 2025), while the average stood at 0.82%.
  • Its Return on Equity has fluctuated over the past 5 years, first soared by 98900bps in 2021, then crashed by -19900bps in 2023.
  • Quarter analysis of 5 years shows iBio's Return on Equity stood at 0.27% in 2021, then crashed by -398bps to 1.37% in 2022, then surged by 57bps to 0.58% in 2023, then crashed by -46bps to 0.85% in 2024, then soared by 48bps to 0.44% in 2025.
  • Its Return on Equity was 0.44% in Q4 2025, compared to 0.57% in Q3 2025 and 1.4% in Q2 2025.